biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	A286BB97-0D7E-4D36-BC5D-E3C853B70277
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A11B-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A11B-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A11B-01A
biospecimen__bio__biospecimen_barcode_bottom	0108433587
biospecimen__bio__day_of_creation	15
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A11B.B53C4282-5266-43FE-A958-19097FD20290.pdf
biospecimen__bio__plate_column	4
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	D
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.00
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2010
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A11B
biospecimen__shared__patient_id	A11B
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	A5751F18-F38E-487E-8745-5D2CC15817DC
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.9
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	1.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.9
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	15
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.2
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	73
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A11B-F38785
clinical__clin_shared__bcr_followup_uuid	2B54DE46-7BF8-4E8A-902A-F85839DC3BE3
clinical__clin_shared__day_of_form_completion	21
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	90
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	RX
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2005
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	d3b39000-277e-49a4-8090-b2be2cb262f8
gdc__aliquots__concentration	0.15
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A11B-01A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	1af96b70-8252-4d7f-8975-358af6b22210
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.92
gdc__analytes__analyte_id	b8b024ee-d5fe-46c3-85cf-d8182ab1ccf8
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	1b1b1af0-b19b-4086-b1b7-669fa0b88235
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:54:50.037061-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	4d670fdc-dd3a-5042-b450-b0ef565ab00c
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1932
gdc__demographic__year_of_death	2005
gdc__diagnoses__age_at_diagnosis	26857
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26857.0
gdc__diagnoses__days_to_death	14.0
gdc__diagnoses__diagnosis_id	262d2169-69bc-541d-a413-2aabdbbf98a8
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	40.90229235981808
gdc__exposures__exposure_id	28f4c6e2-7d17-5603-9ef3-d6d5d269785f
gdc__exposures__height	181.0
gdc__exposures__weight	134.0
gdc__file_id	050a903a-7994-4ae1-96c0-e06cf2522b6d
gdc__file_name	1b0766e1-f7de-44c8-ba72-0c3c086e836f.mirbase21.mirnas.quantification.txt
gdc__file_size	50238
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	c8263a4337ed675d704808a7c64b60b8
gdc__portions__is_ffpe	false
gdc__portions__portion_id	5783d86f-f31d-46cb-97f3-241b0b99ff1e
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1975
gdc__samples__initial_weight	280.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	B53C4282-5266-43FE-A958-19097FD20290
gdc__samples__sample_id	cc6197e4-ec24-4cc7-a69d-e20d4bf14c62
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	BOTTOM
gdc__slides__slide_id	de79efce-c06f-421c-b91d-64403929e118
gdc__submitter_id	mirna_swap_dr11_409_MirnaExpression345b16a2-ef78-4511-9615-e6c346147a25_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	43f9345b-7292-5ae8-b845-058559c8b552
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:21.206+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d3b39000-277e-49a4-8090-b2be2cb262f8-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d3b39000-277e-49a4-8090-b2be2cb262f8-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129609
manually_curated__local_md5	64a97fe6a8994c13650e42c58d9a218d
manually_curated__opengdc_download_date	2018-10-16T17:10:44.000908+02:00
manually_curated__opengdc_file_md5	43c188b02bc1b5e43a985cb8f7ab7340
manually_curated__opengdc_file_size	50237
manually_curated__opengdc_id	d3b39000-277e-49a4-8090-b2be2cb262f8-meq
manually_curated__origin_file_size	129609
manually_curated__origin_last_modified_date	Tue Oct 16 17:14:00 CEST 2018
manually_curated__origin_md5	64a97fe6a8994c13650e42c58d9a218d
manually_curated__tissue_status	tumoral
